Sorry to hear that 3 Flight. Prayers for you and your wife. Hope the fever breaks soon.

WDLF did a smart thing. Yesterday their podcast was thirty minutes. They took the time to only answer questions that had come in from investors. They are doing part two next Monday to give the normal business update. Next week they also start the podcasts for just MJ Link, the first licensee that will IPO. The plan is for them to be listed on the Nasdaq or NYSE when they go public. Pretty smart IR communication strategy. Will keep the shorts on their toes as they will never know when news bombs ?? will drop and/or what information they will share from week to week. They must read very carefully imo.

If we can get .12’s I’ll continue loading the boat. When it is at .50 it will be splitting hairs, even more so when over $1. It’s coming.

Adding here at .16. It won’t be at these levels too long.

Great add to the QSAM board.

“During his tenure at NewLink, Dr. Link led a series of collaborative transactions totaling hundreds of millions of dollars with Merck, Roche and the United States government. He also oversaw the collaboration with Merck to develop EVERBO, the first Ebola vaccine to receive FDA approval.”

Love his FDA approval process and success experiences. Just the type of expertise QSAM needs to take CycloSam through the process to replace the 23 year old drug Quadramet. Obviously time to improve upon an old outdated and harder on the system medication for cancers.

Market Makers such a joke. Had order in at full ask .1698. Did not trigger for a while. Then they just moved the ask you to .17 w no fill. Major game playing here.

10K buy at .1625 was good though. Just keep buying dips.

Nice add. Maybe it was my share count. Either way they ain’t parting with too many shares on the cheap.

Same here I had bid above ask and it did not trigger. Game playing. Only means good things ahead.

I had a buy in on the ask and it did not fill either. I ended up canceling the order. It wasn’t as large as your order but the fact that this is happening on multiple occasions says a lot. The MM’s are manipulating the ask are trying to drive the price down to steal shares cheap imo. I have not felt this good about a position in a long time.

My Ave cost is under .05.

Threelight said it all. I tried to buy on the ask and would not fill either. Any dip, any dip I’m buying and I already have a million and a half shares. I want 2.

It ain’t going under a dime. Mark my words.

I liken the model almost to that of a franchise but it is not technically. Except in this the case the franchisee (called the licensee in their model) will have a company that will go public through the 1A process (likely on the Nasdaq or NYSE according to CEO Ken today) and be publicly traded under its own symbol. WDLF will be like the franchisor who set them up in the business and will own 15% of the company and receive 5% of their revenues for the work they put into setting them up. The licensee will also have a lot of resources at their disposal to help them grow their business and implement best practices to grow their user base and ultimately ad revenues and a platform for e-Commerce, mainly in the form of human capital expertise at Social Life Network and their advisors. It is really a brilliant business model. It is like franchising in the social media world, to allow companies to specialize in a market segment and help move people away from the big social media platforms, which have become too political through censorship. It will give industries that would otherwise be restricted in social media circles because of ideology, a social platform to run their business with fewer restrictions and kick back from the cancel culture that is permeating our society. Brilliant.

Yes it is. Good value un under $1

Yes put in the order and select good to cancel and not Day only.

I think these quiet days we add as the market makers move it up and down. Good luck to us!

In the big picture what it is trading at tomorrow is immaterial to me. I’m adding on dips. Close to the 20M share count now. Anything under .004, time to mortgage the farm.

Adding daily. Taking those low 6’s.

It will take off well before they get to phase 3. They are in the process of launching phase 1. The players involved here developed FDA approved Quadramet. The new drug CycloSam bone cancer drug will improve upon this platform. Same doctors developing CycloSam for QSAM that developed Quadramet. This should fast track through approval process. Current market cap is just ~$15M. Compare this to the cap of other companies with drugs in the approval process. Very strong leadership team.

Funny seeing people post about price going down, now at .0047, when I was buying YESTERDAY at .0037 and .0038. 25% gain since I bought those shares YESTERDAY. So it didn’t hold .0055. Bottom is rising. It will soon break that .0055 level and then that will become new support. Unless of course news breaks and...then who knows where she goes.

Added some at 38. Even tapped a few at 37. Accumulating all I can.

Is a this a rap song? If not, it should be.

Nope. I’m dipping too. Good things ahead as they execute their plan. Big getting the financing this week. Will be good tracking their progress on moving CycloSam through the FDA approval process. Cap will grow quickly as they hit their milestones.

The CEO said a reverse split is off the table for 2021. No concern from me in the share count. It is all relevant to market cap which at current prices, makes this a very undervalued company, IMO of course. Take a look at past podcasts. They are impressive leaders driving this ship. Welcome and good luck. I own a lot shares and believe in time this will play out well for investors.

Added 4 million shares today. Patience will pay off bigly with this one.

I have 11M shares. And will buy more on dips. This is gold. Patience will pay off.

$QSAM cancer treatment drug. Developers of CycloSam same developers of FDA approved drug Quadramet. Had big week last week. Looking for continuation as news on phase 1 is imminent. CEO Douglas Baum and Executive Chairman much experience in FDA approvals.

Has very quietly rebounded nicely from its recent low around $.30 to $.54. As someone who has used and benefited from electro-therapy very excited about where this company is heading. Love seeing alternatives to FDA/big pharma monopoly and their opioid fixation to removing pain.

Totally agree. QSAM is just getting started. Once they report updates on trials and financing anything under $2 will look cheap. Now is the time to buy imo under $1.

Perfectly positioned. Opportunity to launch improved drug of another already FDA approved. Same doctors who developed FDA approved cancer drug Quadramet now developing improved version in Cyclosam. Fast track potential. Clean cap structure.

Just needs some eyes on it to generate volume and with some positive developments it should do quite well. Nice volume on Friday so hopefully that is a start of food things to come.

Mercutos of course. I hold zero now. Hope it goes to the moon for you all. This has been a great board

I actually think the most important part is the development of a drug that can help people with bone cancer. If the drug does what they say it can do it’s got some serious upside from its current market cap. I get what you are saying though. Lots of companies on the OTC use similar services and their stocks perform quite well. We’ll see.

Good things ahead for EMED. In this day and age I love any technology that will help people get off opioids to relieve their pain. With the right financial backing this business can do very well. And I appreciate the passion of the CEO. Good entry on your part by the way.

You make some very good points. And the A/R number may speak to the miss on the preliminary projection. It would have taken nearly the entire A/R number to hit this projection. Strong financial people would not let this happen. If Dave has any thought of upgrading to higher exchanges like the NASDAQ, as he has stated, he needs to mature as a business leader. It won’t happen this type of thing. That is why I have felt the QB was the next best step.

Had they reported that number, though, at $4.3M the stock would have taken a hit imo based on the sequential decline and the fact that investors who have followed the stock for a while expected well over $5.0M for the quarter. It would not have been a record quarter as they said. For the company to remain silent on this just doesn’t work for me personally. Stocks like this move on news. And they have proven to me to be unreliable on their news and PR’s. The rebound in the stock does tell me the market did not care too much about the miss and discrepancy.

I’m moving on. Other fish in the ocean. Good call grabbing more at .165. Hope it holds current levels for all the believers.

Seems reporting this past quarter was a bit of a problem. It is this type of thing that gets slapped with a skull and cross bones if they’re not careful. And if that happened...

So the biggest question and concern I have is around revenues for Q3. SIRC reported $4.33M in revenues for the 3rd quarter ending 11/30. For Q2 they reported $5.34M, so their sequential growth from Q2 to Q3 went down 19%.

The troubling part for me was the press release the company put out on December 16th, two weeks after the quarter ended. In it the company stated the following: the company “announced today that it's preliminary, unaudited third quarter fiscal 2021 revenues totaled a record $5.2 million.” They missed their projection of $5.2M by 17% when they reported $4.33M.

The PR continued: “The record revenue in the third quarter of fiscal 2021 represents over 130% year-over-year growth from $2.3 million in the third quarter of fiscal 2020, driven by continued operational execution and cross-selling synergies across the Company's core business lines.” Because the actual number came in at $4.33M this entire PR is misrepresenting the business. The actual growth rate was 88%, from $2.3 to $4.33M, still an impressive growth rate but way off the 130% they reported.

Please let me know if I am missing something because I do not want to misrepresent the facts. If this is accurate though, for the company to put out a PR with a $5.2M projection two weeks after the quarter ended, boast about it being a record quarter, then not give any reason for the discrepancy between the PR and the actual result is a sign of incompetence by management. Finally and again, I am open to any counter argument on the facts here.

Let me know if I am wrong. I will gladly admit my error. Until then and because of this, like they say on Shark Tank, “I’m out”. GLTA.

Did anyone ever learn anything about the PR that states $5.3M unaudited revenues a couple weeks ago and then the ~$4.3M reported in their earnings yesterday?

Dave has been focused on QX for a long time. He just needs to get the QB uplisting done and not give thought to a reverse split or anything else to get the price where it needs to be for QX. We don’t need pie in the sky thinking right now. Get it uplisted now imo and continue working toward a profitable enterprise. And thanks for the reminder on price levels for both.